Surufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metastatic Pancreatic Cancer
Clinical trial NCT05481476 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05481476
- Sponsor
- Sun Yat-sen University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-12
- Primary completion
- 2025-12-31
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.